Nanoparticles comprising aminoacyl trna synthetase and anticancer composition comprising same
AssigneeMedicinal Bioconvergence Research Center
InventorsSunghoon Kim, Min Chul Park
Life of this patent
Estimating the term…
Abstract
The present invention relates to nanoparticles comprising aminoacyl tRNA synthetase and an anticancer composition comprising the same and, specifically, to nanoparticles which comprise glycyl-tRNA synthetase (GRS), leucyl-tRNA synthetase (LRS), and isoleucyl-tRNA synthetase (IRS), and have anticancer or immunostimulating activity; a pharmaceutical composition for preventing or treating cancer, comprising the nanoparticles as an active ingredient; a composition for immunostimulation; and a method for preparing the nanoparticles.
Claims19
nanoparticles comprising glycyl-tRNA synthetase (GRS), leucyl-tRNA synthetase (LPS), and isoleucyl-tRNA synthetase (IRS) and possessing an activity of treating cancer or enhancing immune function.
Dependencies are inferred from the claim text.